The neuroendocrine transition in prostate cancer is dynamic and dependent on ASCL1
Published in Nature Cancer, 2024
Recommended citation: Romero, R., et al. Nature Cancer 5, 1641–1659 (2024). https://doi.org/10.1038/s43018-024-00838-6
This study uses experimental models and molecular profiling to examine how prostate cancer transitions to a neuroendocrine state. It investigates the role of ASCL1 in that transition and how cellular states change during tumor progression.